RIBESKIN MED & TurtlePin III at AMWC 2022
RIBESKIN MED|TurtlePinIII Team would like to sincerely thank all of our beloved visitors and partners from AMWC Monaco 2022!
It was another highly successful and meaningful experience of meeting with enthusiastic visitors and partners showcasing TurtlePinIII and RIBESKIN MED with its renewed product line!
TURTLEPINIII is an innovative 32G hypodermic multi-needles, which can be integrated into various professional procedures of choice. TurtlePin allows for a highly effective drug delivery with an increased absorption rate by up to 30 times higher than topical application and by up to 15 times higher than MTS devices. The lancet x 2 cut of the needles also allows for an effective penetration with minimal pain and reduced risk of injury.
Dedicated to developing research-driven, patient-centric medical aesthetic products for medical aesthetic professionals, each RIBESKIN MED product is developed after years of intensive research collaborating closely with hospitals, laboratories and industry experts, providing innovative medical aesthetic solutions for experts by experts.
For those who have missed the opportunity to meet us at AMWC 2022, we look forward to seeing you at IMCAS, Paris in June, where TurtlePin III and RIBESKIN MED will be present next!
See you again soon at IMCAS, Paris!
